CVRx (CVRX) EPS (Basic) Growth (1y) (2021 - 2026)
CVRx (CVRX) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 13.85% |
| 10 | CVRx | 75.83 Mn | 11.25 Mn | 13.72 Mn | 6.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29% |
| Mar 31, 2026 | 6.43% |
| Dec 31, 2025 | 3.05% |
| Sep 30, 2025 | 14.46% |
| Jun 30, 2025 | 12.86% |
| Mar 31, 2025 | 49.09% |
| Dec 31, 2024 | -8.63% |
| Sep 30, 2024 | -32.72% |
| Jun 30, 2024 | -15.31% |
| Mar 31, 2024 | -90.11% |
| Dec 31, 2023 | 15.34% |
| Sep 30, 2023 | 9.32% |
| Jun 30, 2023 | -4.19% |
| Mar 31, 2023 | -12.52% |
| Dec 31, 2022 | 49.71% |
| Sep 30, 2022 | -56.77% |
| Jun 30, 2022 | 98.89% |
| Mar 31, 2022 | 97.96% |
| Dec 31, 2021 | 88.39% |
| Sep 30, 2021 | 96.60% |